Portal Instruments is a clinical stage, privately funded, medical device company that specializes in advanced drug delivery. Their main focus is on solving the challenge of self-administering biological medicines through needle-free injections. With the goal of replacing traditional needles and syringes, Portal Instruments is developing a highly innovative needle-free jet injection platform licensed from MIT.

They aim to transform the drug delivery experience for patients suffering from chronic diseases. Portal Instruments values patient-centricity and is dedicated to improving the patient experience and outcome. They also partner with pharmaceutical companies to enhance and enable life-changing therapies.

The company brings innovative, creative, and disruptive ideas to the field of drug delivery and holds themselves to the highest standards of honesty, integrity, and intellectual rigor. Portal Instruments' plan is to build a needle-free drug delivery system that is transformative, interactive, and easy to use. They work alongside pharmaceutical partners to develop and bring to market biologics and biosimilars that treat chronic diseases.

With a passionate and experienced team, Portal Instruments is committed to revolutionizing drug delivery and improving the lives of patients worldwide